MDMA-Assisted Therapy in the Treatment of Posttraumatic Stress Disorder (PTSD)
Principal Investigator: Nasser Shuriquie, M.D. and TBD
Location: Amman, Jordan
This study has been rejected by the Jordanian Food and Drug Administration (JFDA). MAPS will work with researchers to obtain government approval for this study when we begin planning for Phase 3 of our MDMA-assisted psychotherapy for PTSD development program. We hope to enroll Iraqi refugees living in Jordan who have PTSD, along with other Jordanians suffering from PTSD.
- Revised protocol (PDF)
- Revised One Page Protocol Synopsis (PDF)
- Case Report Forms (PDF)
- Curriculum Vitae of Principle Investigator (PDF)